The growing evidence supporting mid-life psa testing

The growing evidence supporting mid-life psa testing

Play all audios:

Loading...

Serum PSA testing remains controversial as the data regarding its utility are conflicting. However, a recent study adds to the growing body of evidence supporting its usefulness in middle-aged men, especially in the determination of the long-term risk of metastasis and death from prostate cancer. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES * National Cancer Institute. _Surveillance Epidemiology and End Results_ [online]. * Nadler, R. B., Humphrey, P. A., Smith, D. S., Catalona, W. J. & Ratliff, T. L. Effect of Inflammation and Benign Prostatic Hyperplasia on Elevated Serum Prostate-Specific Antigen Levels. _J. Urol._ 154, 407–413 (1995). Article  CAS  Google Scholar  * Moyer, V. A. & US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. _Ann. Intern. Med._ 157, 120–134 (2012). Article  Google Scholar  * Carter, H. B. _ et al_. Early Detection of Prostate Cancer: AUA Guideline. _J. Urol._ doi:10.1016/j.juro.2013.04.119. * Vickers, A. J. _ et al_. Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40–55 and long term risk of metastasis: case-control study. _BMJ_ 346, f2023 (2013). Article  Google Scholar  * Loeb, S., Carter, H. B., Catalona, W. J., Moul, J. W. & Schroder, F. H. Baseline prostate-specific antigen testing at a young age. _Eur. Urol._ 61, 1–7 (2012). Article  Google Scholar  * Ulmert, D. _ et al_. Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study, _BMC Med._ 6, 6 (2008). Article  Google Scholar  * Vickers, A. J. _ et al_. Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study. _BMJ_ 341, c4521 (2010). Article  Google Scholar  * Grenabo Bergdahl, A., Holmberg, E., Moss, S. & Hugosson, J. Incidence of Prostate Cancer After Termination of Screening in a Population-based Randomised Screening Trial. _Eur. Urol._ doi:10.1016/j.eururo.2013.05.024. * Scosyrev, E., Messing, E., Mohile, S., Golijanin, D. & Wu, G. Prostate Cancer in the Elderly: Frequency of Advanced Disease at Presentation and Disease-Specific Mortality. _J. Urol._ 187, E137–E138 (2012). Google Scholar  Download references ACKNOWLEDGEMENTS We thank Stacy Loeb for reviewing this manuscript. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of Urology, Northwestern University, Feinberg School of Medicine, 303 East Chicago Avenue, Tarry 16-703, Chicago, 60611-3008, IL, USA Daniel Reinhardt & William J. Catalona Authors * Daniel Reinhardt View author publications You can also search for this author inPubMed Google Scholar * William J. Catalona View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to William J. Catalona. ETHICS DECLARATIONS COMPETING INTERESTS W. J. Catalona declares that he has received research support and honoraria for speaking and been an investigator for Beckman-Coulter, has received research support and royalties as co-inventor from and been an investigator and consultant for OHMX, has received research support from and been an investigator for deCODE genetics, and has been an investigator for Nanosphere. D. Reinhardt declares no competing interests. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Reinhardt, D., Catalona, W. The growing evidence supporting mid-life PSA testing. _Nat Rev Urol_ 10, 436–438 (2013). https://doi.org/10.1038/nrurol.2013.144 Download citation * Published: 02 July 2013 * Issue Date: August 2013 * DOI: https://doi.org/10.1038/nrurol.2013.144 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative

Serum PSA testing remains controversial as the data regarding its utility are conflicting. However, a recent study adds to the growing body of evidence supporting its usefulness in


middle-aged men, especially in the determination of the long-term risk of metastasis and death from prostate cancer. Access through your institution Buy or subscribe This is a preview of


subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only


$17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout


ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES * National Cancer Institute. _Surveillance Epidemiology


and End Results_ [online]. * Nadler, R. B., Humphrey, P. A., Smith, D. S., Catalona, W. J. & Ratliff, T. L. Effect of Inflammation and Benign Prostatic Hyperplasia on Elevated Serum


Prostate-Specific Antigen Levels. _J. Urol._ 154, 407–413 (1995). Article  CAS  Google Scholar  * Moyer, V. A. & US Preventive Services Task Force. Screening for prostate cancer: US


Preventive Services Task Force recommendation statement. _Ann. Intern. Med._ 157, 120–134 (2012). Article  Google Scholar  * Carter, H. B. _ et al_. Early Detection of Prostate Cancer: AUA


Guideline. _J. Urol._ doi:10.1016/j.juro.2013.04.119. * Vickers, A. J. _ et al_. Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40–55


and long term risk of metastasis: case-control study. _BMJ_ 346, f2023 (2013). Article  Google Scholar  * Loeb, S., Carter, H. B., Catalona, W. J., Moul, J. W. & Schroder, F. H. Baseline


prostate-specific antigen testing at a young age. _Eur. Urol._ 61, 1–7 (2012). Article  Google Scholar  * Ulmert, D. _ et al_. Prostate-specific antigen at or before age 50 as a predictor


of advanced prostate cancer diagnosed up to 25 years later: a case-control study, _BMC Med._ 6, 6 (2008). Article  Google Scholar  * Vickers, A. J. _ et al_. Prostate specific antigen


concentration at age 60 and death or metastasis from prostate cancer: case-control study. _BMJ_ 341, c4521 (2010). Article  Google Scholar  * Grenabo Bergdahl, A., Holmberg, E., Moss, S.


& Hugosson, J. Incidence of Prostate Cancer After Termination of Screening in a Population-based Randomised Screening Trial. _Eur. Urol._ doi:10.1016/j.eururo.2013.05.024. * Scosyrev,


E., Messing, E., Mohile, S., Golijanin, D. & Wu, G. Prostate Cancer in the Elderly: Frequency of Advanced Disease at Presentation and Disease-Specific Mortality. _J. Urol._ 187,


E137–E138 (2012). Google Scholar  Download references ACKNOWLEDGEMENTS We thank Stacy Loeb for reviewing this manuscript. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of Urology,


Northwestern University, Feinberg School of Medicine, 303 East Chicago Avenue, Tarry 16-703, Chicago, 60611-3008, IL, USA Daniel Reinhardt & William J. Catalona Authors * Daniel


Reinhardt View author publications You can also search for this author inPubMed Google Scholar * William J. Catalona View author publications You can also search for this author inPubMed 


Google Scholar CORRESPONDING AUTHOR Correspondence to William J. Catalona. ETHICS DECLARATIONS COMPETING INTERESTS W. J. Catalona declares that he has received research support and honoraria


for speaking and been an investigator for Beckman-Coulter, has received research support and royalties as co-inventor from and been an investigator and consultant for OHMX, has received


research support from and been an investigator for deCODE genetics, and has been an investigator for Nanosphere. D. Reinhardt declares no competing interests. RIGHTS AND PERMISSIONS Reprints


and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Reinhardt, D., Catalona, W. The growing evidence supporting mid-life PSA testing. _Nat Rev Urol_ 10, 436–438 (2013).


https://doi.org/10.1038/nrurol.2013.144 Download citation * Published: 02 July 2013 * Issue Date: August 2013 * DOI: https://doi.org/10.1038/nrurol.2013.144 SHARE THIS ARTICLE Anyone you


share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the


Springer Nature SharedIt content-sharing initiative